Pioglitazone vs. Placebo in Association With Pegylated Interferon and Ribavirin in HCV Patients With Insulin Resistance

Phase 3 Terminated 40 enrolled French National Agency for Research on AIDS and Viral Hepatitis

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to test whether the correction of insulin resistance with pioglitazone, will improve the response to antiviral treatment.

Timeline

Start: 2009-12-03
Primary completion: 2012-07-06
Completion: 2012-07-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Pioglitazone	Small molecule	45 mg	—

Pioglitazone vs. Placebo in Association With Pegylated Interferon and Ribavirin in HCV Patients With Insulin Resistance

Summary

Timeline

Drugs

Indications